Federal Register #DEA-1776

DEA Notice on Sigma Aldrich Research Biochemicals’ Application to Manufacture Schedule I Cannabimimetic Agents

The U.S. Drug Enforcement Administration issued a regulatory notice about Sigma Aldrich Research Biochemicals, Inc.’s application to manufacture Schedule I cannabimimetic agents. - Government buyer: None; this is a regulatory notice from the U.S. Department of Justice’s Drug Enforcement Administration (DEA), not a procurement opportunity. - Company named: Sigma Aldrich Research Biochemicals, Inc., applicant for bulk-manufacturer registration. - Substance and purpose: Cannabimimetic agents, drug code 7000, Schedule I, for biological and chemical research. The proposed registration would not authorize other activities involving the drug code. - Procurement items: No products or services, part numbers, or quantities are requested. - Notable requirements: Registered bulk manufacturers and applicants may submit comments or objections, or request a hearing, concerning the proposed registration.

Description

Sigma Aldrich Research Biochemicals, Inc. applied to the Drug Enforcement Administration to be registered as a bulk manufacturer of controlled substances. The application covers cannabimimetic agents (drug code 7000), Schedule I. The company plans to manufacture the substance for biological and chemical research, and no other activity for this drug code is authorized under the registration. Comments, objections, or a written request for a hearing may be submitted on or before December 28, 2026.

View original listing